Correction to: Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization
Authors:
Open Access
- 11 June 2020
- journal article
- correction
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 86 (1) , 163